Manassas, VA, United States of America

Pranvera Ikonomi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: American Type Culture Collection. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pranvera Ikonomi. Retrieved from https://idiyas.com/inventor/pranvera-ikonomi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pranvera Ikonomi: Innovator in Diabetes Treatment

Introduction

Pranvera Ikonomi is a notable inventor based in Manassas, Virginia. She has made significant contributions to the field of diabetes research, particularly focusing on type 2 diabetes. Her work aims to improve the diagnosis and treatment of this prevalent condition.

Latest Patents

Pranvera Ikonomi holds a patent for "Methods for treatment of type 2 diabetes." This invention relates to the identification of biological markers associated with an increased risk of developing diabetes. The methods outlined in her patent provide new avenues for diagnosis and prognosis, potentially leading to innovative therapeutic targets for the treatment or prevention of diabetes.

Career Highlights

Ikonomi is affiliated with the American Type Culture Collection, where she applies her expertise in biological research. Her work has been instrumental in advancing the understanding of diabetes and its associated risks.

Collaborations

Some of her notable coworkers include Cohava Gelber and Liping Liu, who contribute to the collaborative efforts in diabetes research.

Conclusion

Pranvera Ikonomi's innovative work in identifying biological markers for diabetes showcases her commitment to improving health outcomes for individuals at risk of this disease. Her contributions are paving the way for future advancements in diabetes treatment and prevention.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…